Abbott Laboratories (TSX:ABT)
Canada · Delayed Price · Currency is CAD 22.19
0.00 (0.00%)
Dec 29, 2025, 9:30 AM EST
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of CAD 299.29 billion as of December 31, 2025. Its market cap has increased by 6.83% in one year.
Market Cap
299.29B
Enterprise Value
306.89B
Revenue
61.07B
Ranking
n/a
PE Ratio
15.43
Stock Price
22.19
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 299.29B, an increase of 46,937.38%. That is a compound annual growth rate of 11.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 299.29B | 6.03% |
| Dec 31, 2024 | 282.28B | 11.86% |
| Dec 29, 2023 | 252.36B | -2.60% |
| Dec 30, 2022 | 259.08B | -15.18% |
| Dec 31, 2021 | 305.44B | 27.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Constellation Software | 70.88B |
| Celestica | 47.78B |
| CGI Inc. | 27.88B |
| Topicus.com | 10.52B |
| The Descartes Systems Group | 10.47B |
| Lumine Group | 7.06B |
| Kinaxis | 4.94B |
| BlackBerry | 3.13B |